Dry AMD is a disease that is highly prevalent among the aging population and does not yet have an effective therapy (unlike wet AMD for which we have an increasing arsenal of treatment options). Despite skepticism from the medical community, it is heartening to see the positive results of ozone therapy which has improved the vision of patients almost blind from dry AMD. In this issue, there are two trials reviewed that explore the use of ozone therapy in dry age-related macular degeneration (AMD), which is a global public health problem and one of the three main causes of blindness. Another potentially innovative treatment for a technically complex ocular problem, intracorneal rings for keratoconus, is discussed by Ibrahim et al.
This current issue presents a review of promising research in the use stem cell therapy to restore retinitis pigmentosa, which currently is an untreatable condition. Below we discuss the VISION 2020 program global activities in the prevention of blindness.
We hope that such progressive thinking regarding visual impairment can be extended outside the clinical setting and into the communities, the schools, the nursing facilities, and homes of the patient population. The content focuses on difficult-to-treat diseases that encourage us as eye care professionals to think outside the box, or in our case, slit lamp. In its scope as a peer-reviewed journal, it covers articles and studies from leading causes of preventable blindness to promising advanced medical therapies. We applaud the authors and editors of this second issue of the Medical Hypothesis, Discovery, and Innovation Ophthalmology Journal in 2013 for presenting new research and innovative ideas on the vast array of issues and diseases related to ocular health.
0 kommentar(er)
